Melatonine Ace (Melatonin)

Melatonin acts as an agonist at the MT1 and MT2 receptors located in the suprachiasmatic nucleus of the brain. Activation of these receptors mimics the hormone’s natural nighttime rise, signaling the body that it is dark, which helps to synchronize the internal clock and promote sleep initiation.

The appropriate dose of Melatonine Ace is determined by the prescribing healthcare professional based on the individual’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for melatonin use during pregnancy or lactation are limited. Healthcare providers generally advise caution and may recommend avoiding the product unless the potential benefit outweighs any possible risk. Patients should discuss their specific situation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melatonin differs from traditional sedative sleep aids such as benzodiazepines or antihistamines because it works by regulating the circadian clock rather than directly depressing the central nervous system. This mechanism often results in fewer next‑day residual effects, but its efficacy is most pronounced when the sleep problem is related to timing rather than severe insomnia.

Melatonine Ace should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct light. Keeping the product in a dry, cool environment helps maintain its potency and ensures stability throughout its shelf life.

The product is taken orally, typically with a glass of water. It is usually recommended to ingest the dose shortly before the desired bedtime, following the timing guidance provided by the prescriber to align with the natural rise of endogenous melatonin.

Serious but uncommon risks include severe allergic reactions such as rash, itching, swelling or anaphylaxis, and mood disturbances like depression or agitation. Hormonal effects, such as changes in menstrual cycles, have also been reported. Any of these symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin or any excipients in the formulation should avoid use. Patients with uncontrolled epilepsy, severe depression, or those taking medications that may interact significantly (e.g., anticoagulants, CNS depressants) should consult a healthcare professional before starting therapy.